RACHEL MCCOY: Open Payments
NPI 1639884968 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 28 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $364 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $150 |
| Lilly USA, LLC | 11 | $133 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Novo Nordisk Inc | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: MOUNJARO, VRAYLAR, QULIPTA, FARXIGA, Ozempic, LINZESS, UBRELVY, CAPLYTA.
Industry payments across MS — which companies pay providers there.
